Title:
ISOQUINOLINYLSULFONYL DERIVATIVE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/015608
Kind Code:
A1
Abstract:
Disclosed are a class of isoquinoline compounds acting as RHO protein kinase inhibitors, and the use thereof in the preparation of a drug for treating diseases associated with RHO protein kinase. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof.
Inventors:
YAO YUANSHAN (CN)
ZHANG LI (CN)
CHEN ZHAOGUO (CN)
ZHAO LELE (CN)
WU LINGYUN (CN)
CHEN SHUHUI (CN)
ZHANG LI (CN)
CHEN ZHAOGUO (CN)
ZHAO LELE (CN)
WU LINGYUN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2018/096134
Publication Date:
January 24, 2019
Filing Date:
July 18, 2018
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D487/04; A61K31/4725; A61K31/55; A61P9/10; A61P9/12; A61P27/06; C07D401/12; C07D471/04
Domestic Patent References:
| WO2004106325A1 | 2004-12-09 | |||
| WO2015165341A1 | 2015-11-05 |
Foreign References:
| CN105085525A | 2015-11-25 |
Other References:
See also references of EP 3656772A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: